SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-018666
Filing Date
2022-03-14
Accepted
2022-03-14 19:58:54
Documents
2
Period of Report
2022-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4022
2 POA DOCUMENT poa.txt EX-24 3725
  Complete submission text file 0001209191-22-018666.txt   9187
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142
Business Address
Call Matthew (Reporting) CIK: 0001816207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39401 | Film No.: 22738428